Factors | No. | % | |
Patients | 41 | 100.0 | |
Age (mean) | 57.5 (30.8 - 82.3) | ||
Pathological type | |||
Ductal carcinoma | 32 | 78.0 | |
Lobular carcinoma | 5 | 12.2 | |
Mucinos carcinoma | 2 | 4.9 | |
Unknown | 2 | 4.9 | |
Nuclear grade | |||
1 | 2 | 6.3 | |
2 | 9 | 28.1 | |
3 | 21 | 65.6 | |
Subtype | |||
ER+/HER2+ | 3 | 7.3 | |
ER+/HER2− | 10 | 24.4 | |
ER−/HER2+ | 13 | 31.7 | |
ER−/HER2− | 15 | 36.6 | |
Tumor size | |||
T1 | 4 | 9.8 | |
T2 | 25 | 61.0 | |
T3 | 4 | 9.8 | |
T4 | 8 | 19.4 | |
Lymph node metastasis | |||
Negative | 11 | 26.8 | |
Positive | 30 | 73.2 | |
Stage (*1) | |||
2 | 18 | 43.9 | |
3 | 14 | 34.1 | |
4 | 9 | 22.0 | |
Number of brain metastasis | |||
1 | 12 | 29.3 | |
1< | 29 | 70.7 | |
ECOG PS | |||
0 | 8 | 19.5 | |
1 | 10 | 24.4 | |
2 | 9 | 22.0 | |
3 | 8 | 19.5 | |
4 | 6 | 14.6 | |